<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: The RNASE III endonuclease Dicer is one of the key enzymes of microRNA biogenesis </plain></SENT>
<SENT sid="1" pm="."><plain>The influence of Dicer-expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells on the prognosis of patients with several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> has been studied with controversial results among different <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types </plain></SENT>
<SENT sid="2" pm="."><plain>To date no one has examined the effect of this biomarker on survival in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, we aimed to study the influence of Dicer expression on survival in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We performed immunohistochemical analyses on formalin-fixed paraffin embedded (FFPE) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue with an antibody against the Dicer protein </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumour</z:e> material from 237 cases was available from patients with colorectal adeonocarcinomas with moderate differentiation (G2) and without evidence of lymph-node (N0) or distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (M0) </plain></SENT>
<SENT sid="6" pm="."><plain>Sixty-four cases were in T2 and 173 in T3 stages </plain></SENT>
<SENT sid="7" pm="."><plain>A tissue microarray (<z:chebi fb="39" ids="18139,53050">TMA</z:chebi>) was constructed with each <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> in triplicate </plain></SENT>
<SENT sid="8" pm="."><plain>Each <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> was assigned to a scoring scale of 0-3, depending on the cytoplasmatic expression of Dicer </plain></SENT>
<SENT sid="9" pm="."><plain>A Kaplan-Maier analysis was performed and the log-rank test was used for significance levels by using SPSS v.17 software </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: The expression of Dicer in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> shows a strong association with poor survival (<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specific survival=CSS, p&lt;0,001) as well as with reduced progression free survival (PFS, p&lt;0,001) </plain></SENT>
<SENT sid="11" pm="."><plain>In the group with no Dicer staining there was no recorded relapse (0/15) compared with 10/18 relapses in the group with the strongest staining of Dicer </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Strong expression of the central microRNA biosynthesis enzyme Dicer predicts poor prognosis in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>This is in line with investigations on <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>Contradictory, in breast, lung and <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovary cancer</z:e> Dicer has been shown to be a marker of good prognosis </plain></SENT>
<SENT sid="15" pm="."><plain>Further studies on the cellular functions of Dicer need to address these issues </plain></SENT>
</text></document>